[{'source': 'NIAID/NIH', 'target': 'humans', 'rela': 'have crossed the species barrier into', 'type': 'resolved'}, {'source': 'global viromics projects', 'target': 'thousands of coronavirus sequences', 'rela': 'have discovered', 'type': 'resolved'}, {'source': 'cell types', 'target': 'different species', 'rela': 'to be infect from', 'type': 'resolved'}, {'source': 'B', 'target': 'an unknown receptor', 'rela': 'viruses to enter human cells through', 'type': 'resolved'}, {'source': 'human cells', 'target': 'an unknown receptor', 'rela': 'to be enter through', 'type': 'resolved'}, {'source': 'B', 'target': 'human cells', 'rela': 'viruses to enter', 'type': 'resolved'}, {'source': 'host protease processing', 'target': 'a significant barrier', 'rela': 'is', 'type': 'resolved'}, {'source': 'different lineage B viruses', 'target': 'entry)[attrib=We also demonstrate]', 'rela': 'can recombine to gain', 'type': 'resolved'}, {'source': 'several genetically related viruses', 'target': 'Chinese Horseshoes bats', 'rela': 'Shortly thereafter were identified in', 'type': 'resolved'}, {'source': 'most of these viruses', 'target': 'humans', 'rela': 'have never been found in', 'type': 'resolved'}, {'source': 'The ¦Â-CoVs', 'target': 'four lineages', 'rela': 'are further divided into', 'type': 'resolved'}, {'source': 'lineage B', 'target': 'virus sequences', 'rela': 'published', 'type': 'resolved'}, {'source': 'MERSCoV', 'target': 'over 500 viral sequences', 'rela': 'has', 'type': 'resolved'}, {'source': 'additional novel CoV sequences', 'target': 'Every year', 'rela': 'are discovered in', 'type': 'resolved'}, {'source': 'these novel viruses', 'target': 'the potential', 'rela': 'have', 'type': 'resolved'}, {'source': 'it', 'target': 'unknown', 'rela': 'Therefore is', 'type': 'resolved'}, {'source': 'they', 'target': 'the scale', 'rela': 'are discovered in', 'type': 'resolved'}, {'source': 'Cell entry', 'target': 'cross-species transmission', 'rela': 'is an essential component of', 'type': 'resolved'}, {'source': 'Cell entry', 'target': 'the ¦Â-CoVs', 'rela': 'is an essential component of cross-species transmission for', 'type': 'resolved'}, {'source': 'the spike fusion peptide', 'target': 'the spike', 'rela': 'be releases by', 'type': 'resolved'}, {'source': 'the spike RBD', 'target': 'the structural information', 'rela': 'is capable of', 'type': 'resolved'}, {'source': 'the 2019-nCoV spike', 'target': 'January 2020', 'rela': 'emerged in', 'type': 'resolved'}, {'source': 'the 2019-nCoV spike', 'target': 'China', 'rela': 'emerged in', 'type': 'resolved'}, {'source': 'several previously-unappreciated viruses', 'target': 'compatibility)[attrib=We show]', 'rela': 'exhibit', 'type': 'resolved'}, {'source': 'lineage B RBDs', 'target': 'distinct clades)[attrib=We show]', 'rela': 'divide into', 'type': 'resolved'}, {'source': 'host protease processing', 'target': 'the RDB-receptor interaction', 'rela': 'is another species barrier beyond', 'type': 'resolved'}, {'source': 'RaKSM-2.5 primary cells', 'target': 'this study similar', 'rela': 'have were immortalized in', 'type': 'resolved'}, {'source': 'silent mutations', 'target': 'codons 308', 'rela': 'were introduced around', 'type': 'resolved'}, {'source': 'KpnI and XhoI', 'target': 'sites', 'rela': 'digest', 'type': 'resolved'}, {'source': 'silent mutations', 'target': 'SARS-CoV spike', 'rela': 'were introduced for', 'type': 'resolved'}, {'source': 'silent mutations', 'target': 'codons 290', 'rela': 'were introduced around', 'type': 'resolved'}, {'source': 'silent mutations', 'target': 'As6526 spike', 'rela': 'were introduced for', 'type': 'resolved'}, {'source': 'silent mutations', 'target': 'codons 295', 'rela': 'were introduced around', 'type': 'resolved'}, {'source': 'silent mutations', 'target': 'BM48-31 spike', 'rela': 'were introduced for', 'type': 'resolved'}, {'source': 'These engineered spike sequences', 'target': 'pcDNA3.1+', 'rela': 'be cloned into', 'type': 'resolved'}, {'source': 'Spike RBDs', 'target': 'first', 'rela': 'were', 'type': 'resolved'}, {'source': 'RBD inserts', 'target': 'water and Infusion', 'rela': 'were resuspended in', 'type': 'resolved'}, {'source': 'All DNA constructs', 'target': 'Sanger', 'rela': 'were verified by', 'type': 'resolved'}, {'source': 'BHK cells', 'target': 'black 96-well plates', 'rela': 'were seeded in', 'type': 'resolved'}, {'source': '293T cells', 'target': '6-well plates pre-coated', 'rela': 'were seeded onto', 'type': 'resolved'}, {'source': 'transfected cells', 'target': 'VSV¦¤G particles', 'rela': 'Twenty-four hours later were infected with', 'type': 'resolved'}, {'source': 'cells', 'target': '2mL DMEM', 'rela': 'be incubated in', 'type': 'resolved'}, {'source': 'Target cells', 'target': 'triplicate', 'rela': 'were seeded in', 'type': 'resolved'}, {'source': 'pseudotype stocks', 'target': 'DMEM', 'rela': 'were diluted 1:1 in', 'type': 'resolved'}, {'source': 'pseudotype stocks', 'target': 'FBS', 'rela': 'were diluted 1:1 without', 'type': 'resolved'}, {'source': 'pseudotype stocks', 'target': '1:1', 'rela': 'were diluted', 'type': 'resolved'}, {'source': 'pseudotype stocks', 'target': 'trypsin experiments', 'rela': 'were diluted 1:1 for', 'type': 'resolved'}, {'source': '1:1', 'target': '2 %', 'rela': 'supplemented with', 'type': 'resolved'}, {'source': 'Samples', 'target': 'cells', 'rela': 'added to', 'type': 'resolved'}, {'source': 'Inoculated plates', 'target': '1200xG', 'rela': 'were centrifuged at', 'type': 'resolved'}, {'source': 'Bright-Glo luciferase reagent', 'target': 'each well', 'rela': 'Approximately 18-20 hours post-infection was added to', 'type': 'resolved'}, {'source': 'the relative light unit', 'target': 'the plate', 'rela': 'be normalizing to', 'type': 'resolved'}, {'source': 'the relative light unit', 'target': 'average', 'rela': 'be normalizing rlu', 'type': 'resolved'}, {'source': 'Lysates and concentrated particles', 'target': 'FLAG', 'rela': 'were analyzed for', 'type': 'resolved'}, {'source': 'Accession numbers', 'target': 'figure s1b', 'rela': 'can be found in', 'type': 'resolved'}, {'source': 'We', 'target': 'the codon', 'rela': 'introduced silent mutations in', 'type': 'resolved'}, {'source': 'We', 'target': 'silent mutations', 'rela': 'introduced', 'type': 'resolved'}, {'source': 'silent mutations', 'target': 'the codon', 'rela': 'be introduced in', 'type': 'resolved'}, {'source': 'All lineage B sequences', 'target': '29 unique RBD sequences', 'rela': 'parsed to', 'type': 'resolved'}, {'source': 'All lineage B sequences', 'target': 'online repositories', 'rela': 'were downloaded from', 'type': 'resolved'}, {'source': 'All lineage B sequences', 'target': 'downloaded', 'rela': 'were', 'type': 'resolved'}, {'source': 'these RBD clades', 'target': 'not apparent', 'rela': 'were', 'type': 'resolved'}, {'source': 'a lentiviral pseudotypes', 'target': 'viral entry', 'rela': 'have failed to accurately reflect', 'type': 'resolved'}, {'source': 'All constructs', 'target': 'similar levels of expression', 'rela': 'exhibited', 'type': 'resolved'}, {'source': 'All constructs', 'target': 'the chimera', 'rela': 'exhibited similar levels of expression in producer cells and incorporation except', 'type': 'resolved'}, {'source': 'All constructs', 'target': 'VSV pseudotypes', 'rela': 'exhibited similar levels of expression in producer cells and incorporation into', 'type': 'resolved'}, {'source': 'similar levels of expression', 'target': 'VSV pseudotypes', 'rela': 'be exhibited into', 'type': 'resolved'}, {'source': 'similar levels of expression', 'target': 'the chimera', 'rela': 'be exhibited except', 'type': 'resolved'}, {'source': 'We', 'target': 'BHK cells', 'rela': 'then infected', 'type': 'resolved'}, {'source': '1 infected cells', 'target': 'African green monkey kidney', 'rela': 'be only clade human liver from', 'type': 'resolved'}, {'source': '1 infected cells', 'target': 'African green monkey kidney', 'rela': 'be only clade porcine kidney from', 'type': 'resolved'}, {'source': 'particles', 'target': 'luciferase signal', 'rela': 'to produce', 'type': 'resolved'}, {'source': 'all cell lines', 'target': 'this study', 'rela': 'be tested in', 'type': 'resolved'}, {'source': 'We', 'target': 'human aminopeptidase N', 'rela': 'also tested', 'type': 'resolved'}, {'source': 'no entry', 'target': 'the absence of receptor', 'rela': 'Importantly was observed in', 'type': 'resolved'}, {'source': 'our study', 'target': 'ongoing', 'rela': 'was', 'type': 'resolved'}, {'source': 'available', 'target': '2019nCoV', 'rela': 'tested the RBD from', 'type': 'resolved'}, {'source': 'available', 'target': 'our assay', 'rela': 'tested the RBD in', 'type': 'resolved'}, {'source': 'available', 'target': 'the RBD', 'rela': 'tested', 'type': 'resolved'}, {'source': 'the sequence', 'target': 'available', 'rela': 'Once was publicly', 'type': 'resolved'}, {'source': 'the RBD', 'target': '2019nCoV', 'rela': 'be tested from', 'type': 'resolved'}, {'source': 'the RBD', 'target': 'our assay', 'rela': 'be tested in', 'type': 'resolved'}, {'source': 'surface', 'target': 'loops', 'rela': 'exposed', 'type': 'resolved'}, {'source': 'these loops', 'target': 'clade 2 and 3', 'rela': 'be Restoring in', 'type': 'resolved'}, {'source': 'these loops', 'target': 'the loops', 'rela': 'be Restoring from', 'type': 'resolved'}, {'source': 'the entire RBM', 'target': 'ACE2 entry)[attrib=these results show]', 'rela': 'is needed for', 'type': 'resolved'}, {'source': 'strong entry signal', 'target': 'protease-treatment', 'rela': 'be consistently gave following', 'type': 'resolved'}, {'source': 'strong entry signal', 'target': 'human cells', 'rela': 'be consistently gave in', 'type': 'resolved'}, {'source': 'it', 'target': 'human cells', 'rela': 'consistently gave strong entry signal in', 'type': 'resolved'}, {'source': 'it', 'target': 'protease-treatment', 'rela': 'consistently gave strong entry signal following', 'type': 'resolved'}, {'source': 'it', 'target': 'strong entry signal', 'rela': 'consistently gave', 'type': 'resolved'}, {'source': 'their RBD', 'target': 'the consensus RBD', 'rela': 'be replacing with', 'type': 'resolved'}, {'source': 'we', 'target': 'SARS-CoV spike', 'rela': 'did for', 'type': 'resolved'}, {'source': 'their RBD', 'target': 'clade 1', 'rela': 'be replacing from', 'type': 'resolved'}, {'source': 'All chimeric constructs', 'target': 'the exception', 'rela': 'expressed similarly with', 'type': 'resolved'}, {'source': 'Protease treatment', 'target': 'no effect', 'rela': 'had', 'type': 'resolved'}, {'source': 'we', 'target': 'a reductionist approach', 'rela': 'took', 'type': 'resolved'}, {'source': 'several spikes', 'target': 'entry', 'rela': 'be testing for', 'type': 'resolved'}, {'source': 'this approach', 'target': 'applicable', 'rela': 'should be', 'type': 'resolved'}, {'source': 'multiple , distinct domains', 'target': 'spike', 'rela': 'be involving in', 'type': 'resolved'}, {'source': 'a multi-step process', 'target': 'spike', 'rela': 'involving multiple , distinct domains in', 'type': 'resolved'}, {'source': 'the RBD :receptor interaction', 'target': 'this process', 'rela': 'is studied in', 'type': 'resolved'}, {'source': 'human cells', 'target': 'an unidentified receptor', 'rela': 'can be enter through', 'type': 'resolved'}, {'source': 'HKU5 and PDF-2180 spikes', 'target': 'an unidentified receptor', 'rela': 'can enter human cells through', 'type': 'resolved'}, {'source': 'HKU5 and PDF-2180 spikes', 'target': 'human cells', 'rela': 'can enter', 'type': 'resolved'}, {'source': 'protease', 'target': 'it30', 'rela': 'to activate', 'type': 'resolved'}, {'source': 'protease', 'target': 'the receptor', 'rela': 'may act as well on', 'type': 'resolved'}, {'source': 'Addition of protease', 'target': 'low-expression of ACE2', 'rela': 'facilitated entry in cells with', 'type': 'resolved'}, {'source': 'Addition of protease', 'target': 'entry', 'rela': 'facilitated', 'type': 'resolved'}, {'source': 'entry', 'target': 'low-expression of ACE2', 'rela': 'be facilitated with', 'type': 'resolved'}, {'source': 'we', 'target': 'infection', 'rela': 'Indeed saw evidence of residual trypsin activity on the cells after', 'type': 'resolved'}, {'source': 'Menachery et al', 'target': 'their trypsin infections26', 'rela': 'also observed cell rounding during', 'type': 'resolved'}, {'source': 'Menachery et al', 'target': 'cell rounding', 'rela': 'also observed', 'type': 'resolved'}, {'source': 'cell rounding', 'target': 'their trypsin infections26', 'rela': 'be also observed during', 'type': 'resolved'}, {'source': 'trypsin', 'target': 'entry of coronaviruses', 'rela': 'is enhancing', 'type': 'resolved'}, {'source': 'These findings', 'target': 'strong agreement', 'rela': 'are in', 'type': 'resolved'}, {'source': 'we', 'target': 'the RBD', 'rela': 'replaced', 'type': 'resolved'}, {'source': 'the protease-dependent entry phenotype', 'target': 'consistent', 'rela': 'Surprisingly was', 'type': 'resolved'}, {'source': 'the protease site', 'target': 'not compatible', 'rela': 'is', 'type': 'resolved'}, {'source': 'clade 1 spikes', 'target': 'cells expressing human ACE2', 'rela': 'enter', 'type': 'resolved'}, {'source': 'clade 1 spikes', 'target': 'addition of protease', 'rela': 'enter cells expressing human ACE2 without', 'type': 'resolved'}, {'source': 'following protease treatment', 'target': 'clade 2 RBDs interact', 'rela': 'suggests that', 'type': 'resolved'}, {'source': 'AJi cells', 'target': 'clade', 'rela': 'Surprisingly were selectively permissive for', 'type': 'resolved'}, {'source': 'AJi cells', 'target': 'permissive', 'rela': 'Surprisingly were selectively', 'type': 'resolved'}, {'source': 'lineage B cell entry', 'target': 'protease treatment', 'rela': 'is still receptor-dependent following', 'type': 'resolved'}, {'source': 'we', 'target': 'any pseudotype entry', 'rela': 'Critically did not observe', 'type': 'resolved'}, {'source': 'lineage B cell entry', 'target': 'receptor-dependent', 'rela': 'is still', 'type': 'resolved'}, {'source': 'our study', 'target': 'ongoing', 'rela': 'was', 'type': 'resolved'}, {'source': 'cell entry of 2019-nCoV', 'target': 'similar', 'rela': 'Interestingly was', 'type': 'resolved'}, {'source': 'More studies', 'target': 'the full spike sequence', 'rela': 'are needed a viral isolate with', 'type': 'resolved'}, {'source': 'More studies', 'target': 'a viral isolate', 'rela': 'are needed', 'type': 'resolved'}, {'source': 'the 14 contact points', 'target': 'insufficient', 'rela': 'was', 'type': 'resolved'}, {'source': 'Coronaviruses', 'target': 'recombination', 'rela': 'frequently undergo', 'type': 'resolved'}, {'source': 'Coronaviruses', 'target': '34,35', 'rela': 'frequently undergo recombination gaining large swaths of genetic material at', 'type': 'resolved'}, {'source': 'recombination', 'target': 'compatibility', 'rela': 'will impart', 'type': 'resolved'}, {'source': 'it', 'target': 'possible', 'rela': 'is', 'type': 'resolved'}, {'source': 'possible', 'target': 'our data', 'rela': 'be Taken together with', 'type': 'resolved'}, {'source': '2019-nCoV', 'target': 'recombination', 'rela': 'arose from', 'type': 'resolved'}, {'source': 'it', 'target': 'possible', 'rela': 'may be', 'type': 'resolved'}, {'source': 'possible', 'target': 'our receptor assay results', 'rela': 'be Taken together with', 'type': 'resolved'}, {'source': 'we', 'target': 'the SARS-As6526 RBD', 'rela': 'saw with', 'type': 'resolved'}, {'source': 'likely', 'target': 'As6526 spike', 'rela': 'be needed in', 'type': 'resolved'}, {'source': 'the full length', 'target': 'cells', 'rela': 'Notably did not enter', 'type': 'resolved'}, {'source': 'lineage B spike proteins', 'target': 'entry', 'rela': 'can recombine to gain', 'type': 'resolved'}, {'source': 'the Rhinolophus cells', 'target': 'this study', 'rela': 'be used in', 'type': 'resolved'}, {'source': 'We', 'target': 'Dr. Anthony Schountz', 'rela': 'would like to thank', 'type': 'resolved'}, {'source': 'We', 'target': 'Dr. Anthony Schountz', 'rela': 'to thank', 'type': 'resolved'}, {'source': 'the genome sequence', 'target': 'the scientific community', 'rela': 'be providing to', 'type': 'resolved'}, {'source': 'The authors', 'target': 'no competing interests', 'rela': 'declare', 'type': 'resolved'}, {'source': 'Pseudotypes', 'target': 'addition', 'rela': 'were either left before', 'type': 'resolved'}, {'source': 'Pseudotypes', 'target': 'trypsin', 'rela': 'were either left with', 'type': 'resolved'}, {'source': 'Luciferase', 'target': 'particles produced without pseudotype', 'rela': 'be normalized to', 'type': 'resolved'}, {'source': 'particles', 'target': 'pseudotype', 'rela': 'be produced without', 'type': 'resolved'}, {'source': 'BHK cells', 'target': 'the coronavirus receptor', 'rela': 'be transfected with', 'type': 'resolved'}, {'source': 'Shown', 'target': '3 replicates', 'rela': 'are data from', 'type': 'resolved'}, {'source': 'Pseudotypes', 'target': 'protease treatment', 'rela': 'were used hDPP4 , hAPN , or empty vector , without', 'type': 'resolved'}, {'source': 'Pseudotypes', 'target': 'cells expressing hACE2', 'rela': 'to infect', 'type': 'resolved'}, {'source': 'Pseudotypes', 'target': 'hDPP4', 'rela': 'were used', 'type': 'resolved'}, {'source': 'loops', 'target': 'gray', 'rela': 'be highlighted in', 'type': 'resolved'}, {'source': 'VSV pseudotypes', 'target': 'the indicated RBD', 'rela': 'were generated with', 'type': 'resolved'}, {'source': 'c', 'target': 'the indicated RBD', 'rela': 'were generated with', 'type': 'resolved'}, {'source': 'Shown', 'target': '3 replicates', 'rela': 'are data for', 'type': 'resolved'}, {'source': 'the native RBD', 'target': 'the clade 1 consensus', 'rela': 'be replacing with', 'type': 'resolved'}, {'source': 'BHK cells', 'target': 'human ACE2', 'rela': 'be transfected with', 'type': 'resolved'}]